Insider Transactions in Q4 2025 at Aprea Therapeutics, Inc. (APRE)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2025
|
John P. Hamill SrVP/CFO/Prin Fin & Acct Ofcr |
BUY
Open market or private purchase
|
Direct |
5,000
+15.28%
|
$5,000
$1.17 P/Share
|
|
Dec 10
2025
|
Marc Duey Director |
BUY
Open market or private purchase
|
Direct |
21,459
+7.73%
|
$21,459
$1.17 P/Share
|